Stroke is one of the few major diseases with a potential cure—yet it remains overlooked and underfunded. On #WTD25, grateful to @MillEtienne & @Forbes for spotlighting that <3% worldwide receive thrombectomy. We can—and must—do better. https://t.co/1lbc2WMgSw

In thrombectomy, lumen is power: Go big or go home. The super-bore Cereglide 92 redefines aspiration: 🔹 82% thrombus reach 🔹 88% reperfusion 🔹 0% perforation or sICH 🔹 FPE in 50% overall, 61% when C-92 reached the clot Proud to co-lead & serve as senior author on this

“You Cannot Manage What You Do Not Measure”—a timeless principle that holds especially true in the fight against stroke. Our latest paper, "You Cannot Manage What You Do Not Measure: Advances in Global Stroke Interventions and the Role of the Mechanical Thrombectomy Access

Fantastic paper by @adicpini shows that in >13k chronic/subacute subdural hematomas, frailty status mattered the least in the 5% that were treated by middle meningeal artery embolization alone. MMAE embo may be used irrespective of frailty status!#frailtyfighters @NRADjournal

August saw the revision of a classic: The Modified Hunt & Hess Scale offers more accurate SAH patient outcome predictions. Validated through 6,000+ cases from Columbia's SHOP database, it aims to replace the widely-used 1968 original scale. https://t.co/4OdkuuJT8Q

Honored to serve as the Senior Investigator for the recently awarded @svinsociety - Pilot Scientific Grant, supporting our highly anticipated #TRIGEMINAL Trial for Migraine Headaches—(The Targeted Relief in Trigeminovascular Headaches through Middle Meningeal Artery

#SVIN24 was a week ago, but the discussions regarding the latest in clinical trial updates are ongoing! Check out these tables that @neurona_critica & I put together to summarize the exciting new studies currently in the works to move us #ForwardTogether ⏩🧠💉🩸 @svinsociety

Mission Thrombectomy is proud to have our Global Chair, Dr. Fawaz Al-Mufti, MD, @almuftifawaz at the UN General Assembly earlier this week in New York City, advocating for Global Thrombectomy access and Stroke care on behalf of us all!! @svinsociety @dyavagal @NguyenThanhMD

Still using the #HuntHess scale from 1968 for SAH prognosis? Many in the US and internationally continue to rely on this classic scale, following guidelines from @DNV_Group and @jcaho. But medicine evolves, and so should our tools. It's prime time for an upgrade hence myself,

Join us on June 14 in NYC on the #cuttingedge of Neurosciences! The inaugural New York Symposium: Innovation in Neurosciences (NYS-IN) Conference #NYSIN24 at the historic New York Academy of Medicine featuring world-class Neurosciences KOLs Register here: https://t.co/8HnD6hudP4

Big congrats ⁦@Katya_Khamzina⁩ ⁦@BowersNsgyLab⁩ for our hard work translating Risk Analysis Index to ICD codes-expanding applicability & maintaining the hx of quality methods for identifying frailty ⁦@PittSurgery⁩ ⁦@HviUpmc⁩

Exciting day with publication in the highest impact factor journal to date of all 100+ publications @JAMANetworkOpen & 2 years of work to do this study @HurleyMedical

Congrats team @JAMANetworkOpen!! Risk Analysis Index for ICD-10 Dx coding (RAI for NIS!) @adicpini @MollReitz huge 🙏 @UPMC’s Dan Hall #frailtyfighters @BowersNsgyLab Adaptation of the Risk Analysis Index for Frailty Assessment Using Diagnostic Codes

Despite being 1 of the most effective interventions in the #medical world, mechanical thrombectomy access for stroke continues to be an issue worldwide. Luckily, @MThrombectomy, @svinsociety, and today, @almuftifawaz, have continued to work towards bridging this access gap. @WHO

LASTE is out! RCT of 333 pts w Large Core Ischemic Stroke of unrestricted size. Thrombectomy assoc. w Lower disability (mRS 4 vs.6🤔) ⬇️ mortality (36vs.55%)& ⬆️ Hmg (9.6vs.5.7%). Are they better off than dead? Family discussion is essential. https://t.co/YwH8wEdB0a

Congratulations! Great teamwork & vital info since Meningiomas are the most common primary brain tumor (30% of all brain tumors) & the silver tsunami is upon us, w/ exponential increases in older Meningioma patients. #frailtyfighters @WHOCenterFrailt @GlobalFrailty

Our 10th Annual #Neurology Resident Research Symposium was a great success last night! Congratulations to organizers Dr. Mary Vo, @ARZ_Neuro_Doc, Amy Kong + all residents and their faculty mentors! @nyphospital @WeillCornell @MSKCancerCenter @WCM_BMRI

Welcome to the #cuttingedge @ the New York Symposium: Innovation in Neurosciences (IN-NYS) #IN2023 @ the @NYAMNYC NY Academy of Medicine! Join neuroscience KOLs as they unveil the latest breakthroughs & experience #Neuroinnovation. Register here: https://t.co/uSO8Qr9EgQ

#BloggingStroke: Understanding Stroke Risks With Assisted Reproductive Technology https://t.co/FSCWHJkYRg In this blog post, @QDing3 discusses #Stroke article by @adicpini et al. @hoomankamel @almuftifawaz

So much to learn and look forward to this coming year with @svinsociety … From the virtual stroke academy lectures, to access to @SVINJournal articles, to our #SVINAM in San Diego this fall … Can’t think of a better idea than signing up and joining us! DM w any questions 🧠